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Ewing’s  sarcoma  was  identiﬁed  by  James  Ewing  in  1921  as
a  perivascular  endothelial  tumor.1 Since  the  1980s,  it  has
been  believed  that  this  tumor  originates  from  mesenchy-
mal,  myeloid,  or  primitive  multipotential  cells.2 Although  it
mostly  originates  from  bones  of  lower  extremities,  it  can
also  arise  from  soft  tissues  such  as  paravertebral  region.
These  small  round  cell  tumors  have  been  termed  Ewing’s
Sarcoma  (ES)/Peripheral  Primitive  Neuroectodermal  Tumor
(PNET)  and  include  ES  of  the  bone,  extraskeletal  ES,  PNET
and  Askin’s  tumor.3
Extraskeletal  ES  rarely  occurs  in  the  head  and  neck  local-
ization,  account  for  only  1--4%  of  all  ES,  and  usually  prefers
mandibula.4 However,  there  are  few  reports  in  the  liter-
ature  of  ES  arising  from  maxillary  sinuses.4,5 The  gender
distribution  is  equal  and  nearly  half  of  the  patients  in  age
between  10  and  20  years  old,  while  70%  are  under  the
age  of  20.6 The  patients  usually  presented  with  painless
swelling  and  symptoms  such  as  anemia,  leukocytosis,  weight
loss,  nasal  congestion  (based  on  the  location),  vision  loss,
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atient  diagnosed  as  ES  in  the  maxillary  sinus.  The  charac-
eristics  of  the  tumor  and  the  clinical  approach  are  reviewed
ith  the  literature.
ase report
n  11  year-old  female  patient  presented  to  our  clinic  with
he  complaint  of  swelling  on  her  right  cheek.  Her  history
evealed  that  the  swelling  had  emerged  2  weeks  prior  and
ad  been  growing  increasingly  since  then.  In  the  physical
xamination,  there  were  no  other  signiﬁcant  ﬁndings  except
n  immobile,  hard  on  palpation  2  ×  2  cm  mass  lesion  on
he  right  cheek.  Laboratory  tests  showed  no  abnormalities.
agnetic  Resonance  Imaging  (MRI)  revealed  a  mass  lesion
entered  in  the  right  maxillary  sinus  extending  to  the  ante-
ior  wall  and  soft  tissue  (Figs.  1  and  2).  No  metastasis  was
dentiﬁed.
On  suspicion  of  malignancy,  the  patient  underwent  open
urgery  by  approaching  through  sublabial  incision  and  sub-
equently  biopsy  specimen  was  submitted  to  pathology.
In  the  histopathological  examination,  the  tumor  showed
losely  packed  uniform  small  round  cells  with  high
uclear/cytoplasmic  ratios  and  ﬁnely  dispersed  chromatin,
ithout  prominent  nucleoli.  Mitotic  ﬁgures  were  numerous.
reas  of  necrosis  were  present.  Immunohistochemically,  the
umor  cells  were  strongly  positive  with  CD99  and  vimentin  as
 Cérvico-Facial. Published by Elsevier Editora Ltda. This is an open
enses/by/4.0/).
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Figure  3  Monoton  tumor  cells  inﬁltrating  stroma.  The  cells
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tigure  1  A  coronal  MRI  of  the  sinuses  revealed  a  mass  in  the
ight maxillary  sinus.
ell.  Occasional  clusters  had  some  cells  positive  for  synap-
ophysin  and  CD56.  The  tumor  cells  were  negative  with
D3,  CD20,  LCA,  PanCK,  myogenin,  myoD1  and  desmin.  Ki-
7  proliferative  index  was  found  between  30%  and  50%  in
ome  areas.  Subsequently,  ES  appeared  as  the  most  prob-
ble  diagnosis.  Therefore  the  patient  material  submitted
o  the  molecular  pathology  for  the  evaluation  of  classical
t
w
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Figure  2  A  axial  MRI  of  the  sinuses  revealave round  nuclei  with  small  and  inconspicuous  nucleoli
arrows)  (hemotoxylin  &  eosin,  ×400).
SWR1-FLI1  rearrangement.  The  results  of  Fluorescence  In
itu  Hybridization  (FISH)  for  ESWR1-FLI1  rearrangement  con-
rmed  the  diagnosis  ES/PNET  (Figs.  3  and  4).
The  patient  was  treated  by  chemotherapy.  Patient
as  treated  with  Ewing’s  sarcoma  VDC/IE  (V,  vincristine
.5  mg/m2;  D,  doxorobucin  75  mg/m2;  C,  cyclophosphamide
.2  g/m2; I,  Ifosphamide  1.8  g/m2; E,  etoposide  100  mg/m2)
ediatric  Oncology  Group  protocol  which  were  administered
7  cycles  over  48  weeks.  During  the  follow-up,  after  4
onths,  local  recurrence  was  detected.  The  patient  under-
ent  open  surgery  with  the  same  procedure  approaching
hrough  sublabial  incision.  The  resection  was  extended
o  reach  safely  negative  tumor  margins.  Radiotherapy
as  added  to  treatment  procedure  following  the  surgery.
he  metastasis  investigation  was  carried  out  by  Positron
ed  a  mass  in  the  right  maxillary  sinus.
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Figure  4  Tumor  cells  are  forming  solid  areas  and  express-
ing synaptophysin  immunohistochemically  (arrows)  (×200).
Corrected  ﬁgure  legends  and  arrows  were  added  to  the
microphotographs.
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RFigure  5  A  coronal  MRI  of  the  sinuses;  mucosal  thickening
appears  in  the  right  maxillary  sinus,  after  treatment.
Emission  Tomography  (PET)  scan  and  MRI  every  6  months.
Also  the  patient  was  followed  by  routine  clinical  examina-
tion  every  3  months.  There  was  no  ﬁnding  of  recurrence  or
metastasis  at  the  13th  month  of  follow-up  (Fig.  5).
Discussion
Extraskeletal  ES  is  a  rare  tumor  in  head  and  neck
region.  The  differential  diagnosis  includes  several  enti-
ties  occurring  at  the  bones  and  soft  tissues  of  sinonasal
tract  such  as  malignant  melanoma,  rhabdomyosarcoma,
sinonasal  undifferentiated  carcinoma,  lymphoma  and  olfac-
tory  neuroblastoma.  In  our  case,  considering  the  patient’s PRESS
3
ge  extraskeletal  ES,  rhabdomyosarcoma  and  lymphoma
ere  included  in  the  differential  diagnosis.  The  possi-
ility  of  rhabdomyosarcoma  and  lymphoma  was  excluded
nd  the  diagnosis  of  extraskeletal  ES  was  conﬁrmed  with
mmunohistochemical  stainings  and  FISH  for  ESWR1-FLI1
earrangement.7
A  majority  of  ES  have  t(11;22)(q24;q12)  which  corre-
ponds  to  a  fusion  between  the  EWS  gene  (22q12)  and  the
LI1  gene  (11q24)  which  is  a  transcription  factor.
Moreover,  four  different  translocations  are  observed.
hose  are  EWS-ERG  t(21;22)(q22;q12),  EWS-ETV1
(7;22)(p22;q12),  EWS-E1AF  t(17;22)(q12;q12),  and
WSFEV  t(2;22)(q33;q12)  according  to  their  frequency,
espectively.8,9 The  detection  of  ESWR1-FLI1  rearrangement
s  not  diagnostic  for  ES,  also  in  rhabdomyosarcoma
t  has  been  observed.10 In  this  case,  histopathologic-
mmunohistochemical  evaluation  in  conjunction  with
olecular  testing  for  ESWR1-FLI1  rearrangement  provide  a
eﬁnitive  diagnosis.  While  evaluating  a patient  for  whom
S  is  suspected  or  diagnosed  deﬁnitely,  appropriate  imaging
ethods  should  be  performed  as  a  ﬁrst  priority.  Computed
omography  is  used  to  monitor  bone  destruction  and  mass
ropagation  ﬁelds,  while  MRI  is  an  ideal  method  for  the
valuation  of  soft  tissue  involvement  around  the  primary
esion.9 In  our  patient,  we  evaluated  the  tumor  extension
y  MRI.
The  aim  of  ES  treatment  is  to  maintain  all  normal  func-
ions  and  to  prevent  recurrences  and  sequellae  in  the
ong  term  while  eliminating  the  disease.  The  recommended
reatment  is  a combination  of  surgery  with  chemother-
py  and  radiotherapy.  Early  diagnosis  followed  by  wide
esection,  chemotherapy,  and  radiotherapy  can  leave  the
atient  disease-free  for  a  long  time.  It  has  been  reported
hat  the  recent  use  of  proton  beam  therapy  provides  local
ontrol  of  the  disease  and  prevents  possible  complications
f  radiotherapy  on  surrounding  tissues  (such  as  vision  loss
nd  intracranial  complications).9,10 In  this  case,  after  recurr-
nces  we  added  the  radiotherapy  to  the  chemotherapy
reatment  following  the  resurgery.
onclusion
wing’s  sarcoma  is  rare  in  the  maxillary  sinus.  Surgery,
hemotherapy,  and  radiotherapy  should  be  used  in  combi-
ation  to  treat  this  lesion,  which  stems  from  high-grade
umors.  Patients  should  be  closely  followed-up  with  due  to
he  possibilities  of  local  recurrence  and  distant  metastasis.
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